1. Home
  2. Long-Acting HIV-1 Capsid

Tag: Long-Acting HIV-1 Capsid

Industry News
Gilead Resubmitted New Drug Application for Lenacapavir, an Investigational, Long-Acting HIV-1 Capsid Inhibitorto U.S. Food and Drug Administration

Gilead Resubmitted New Drug Application for Lenacapavir,...

Jun 30, 2022 0 426

On June 27, 2022,- Gilead Sciences, Inc. announced the resubmission of the New Drug...